View Item 

Show simple item record

TGR 5 signalling inhibits the production of pro‐inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease
dc.contributor.authorYoneno, Kazuakien_US
dc.contributor.authorHisamatsu, Tadakazuen_US
dc.contributor.authorShimamura, Katsuyoshien_US
dc.contributor.authorKamada, Nobuhikoen_US
dc.contributor.authorIchikawa, Rikoen_US
dc.contributor.authorKitazume, Mina T.en_US
dc.contributor.authorMori, Maikoen_US
dc.contributor.authorUo, Michihideen_US
dc.contributor.authorNamikawa, Yukaen_US
dc.contributor.authorMatsuoka, Katsuyoshien_US
dc.contributor.authorSato, Toshiroen_US
dc.contributor.authorKoganei, Kazutakaen_US
dc.contributor.authorSugita, Akiraen_US
dc.contributor.authorKanai, Takanorien_US
dc.contributor.authorHibi, Toshifumien_US
dc.date.accessioned2013-05-02T19:35:06Z
dc.date.available2014-07-01T15:53:31Zen_US
dc.date.issued2013-05en_US
dc.identifier.citationYoneno, Kazuaki; Hisamatsu, Tadakazu; Shimamura, Katsuyoshi; Kamada, Nobuhiko; Ichikawa, Riko; Kitazume, Mina T.; Mori, Maiko; Uo, Michihide; Namikawa, Yuka; Matsuoka, Katsuyoshi; Sato, Toshiro; Koganei, Kazutaka; Sugita, Akira; Kanai, Takanori; Hibi, Toshifumi (2013). " TGR 5 signalling inhibits the production of pro‐inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease." Immunology (1): 19-29. <http://hdl.handle.net/2027.42/97471>en_US
dc.identifier.issn0019-2805en_US
dc.identifier.issn1365-2567en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97471
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherIntestinal Macrophageen_US
dc.subject.otherCrohn's Diseaseen_US
dc.subject.otherBile Aciden_US
dc.subject.otherTumour Necrosis Factor αen_US
dc.subject.otherTGR 5en_US
dc.titleTGR 5 signalling inhibits the production of pro‐inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's diseaseen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23566200en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97471/1/imm12045.pdf
dc.identifier.doi10.1111/imm.12045en_US
dc.identifier.sourceImmunologyen_US
dc.identifier.citedreferenceCalmus Y, Guechot J, Podevin P, Bonnefis MT, Giboudeau J, Poupon R. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor‐α production by monocytes. Hepatology 1992; 16: 719 – 23.en_US
dc.identifier.citedreferenceTakada Y, Hisamatsu T, Kamada N et al. Monocyte chemoattractant protein‐1 contributes to gut homeostasis and intestinal inflammation by composition of IL‐10‐producing regulatory macrophage subset. J Immunol 2010; 184: 2671 – 6.en_US
dc.identifier.citedreferenceDenning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17‐producing T cell responses. Nat Immunol 2007; 8: 1086 – 94.en_US
dc.identifier.citedreferenceAbraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066 – 78.en_US
dc.identifier.citedreferenceRogler G, Andus T, Aschenbrenner E, Vogl D, Falk W, Schölmerich J, Gross V. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 893 – 9.en_US
dc.identifier.citedreferenceRogler G, Hausmann M, Spöttl T et al. T‐cell co‐stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa. Eur J Gastroenterol Hepatol 1999; 11: 1105 – 11.en_US
dc.identifier.citedreferenceKamada N, Hisamatsu T, Okamoto S et al. Unique CD14 + intestinal macrophages contribute to the pathogenesis of Crohn disease via IL‐23/IFN‐γ axis. J Clin Invest 2008; 118: 2269 – 80.en_US
dc.identifier.citedreferenceSchenk M, Bouchon A, Seibold F, Mueller C. TREM‐1‐expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 2007; 117: 3097 – 106.en_US
dc.identifier.citedreferenceKanai T, Watanabe M, Okazawa A et al. Interleukin 18 is a potent proliferetive factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 2000; 119: 1514 – 23.en_US
dc.identifier.citedreferenceKamada N, Hisamatsu T, Honda H et al. Human CD14 + macrophages in intestinal lamina propria exhibit potent antigen‐presenting ability. J Immunol 2009; 183: 1724 – 31.en_US
dc.identifier.citedreferenceTakayama T, Kamada N, Chinen H. et al. Imbalance of NKp44 +  NKp46 – and NKp44 –  NKp46 + natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 2010; 139: 882 – 92.en_US
dc.identifier.citedreferenceWada Y, Hisamatsu T, Kamada N, Okamoto S, Hibi T. Retinoic acid contributes to the induction of IL‐12‐hypoproducing dendritic cells. Inflamm Bowel Dis 2009; 15: 1548 – 56.en_US
dc.identifier.citedreferenceIchikawa R, Takayama T, Yoneno K et al. Bile acids induce monocyte differentiation toward interleukin‐12 hypo‐producing dendritic cells via a TGR5‐dependent pathway. Immunology 2012; 136: 153 – 62.en_US
dc.identifier.citedreferenceKawamata Y, Fujii R, Hosoya M et al. A G protein‐coupled receptor responsive to bile acids. J Biol Chem 2003; 278: 9435 – 40.en_US
dc.identifier.citedreferenceMaruyama T, Miyamoto Y, Nakamura T et al. Identification of membrane‐type receptor for bile acids (M‐BAR). Biochem Biophys Res Commun 2002; 298: 714 – 9.en_US
dc.identifier.citedreferenceMaruyama T, Tanaka K, Suzuki J et al. Targeted disruption of G protein‐coupled bile acid receptor 1 (Gpbar1/M‐Bar) in mice. J Endocrinol 2006; 191: 197 – 205.en_US
dc.identifier.citedreferenceKeitel V, Reinehr R, Gatsios P, Rupprecht C, Görg B, Selbach O, Häussinger D, Kubitz R. The G‐protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 2007; 45: 695 – 704.en_US
dc.identifier.citedreferenceKeitel V, Cupisti K, Ullmer C, Knoefel WT, Kubitz R, Häussinger D. The membrane‐bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology 2009; 50: 861 – 70.en_US
dc.identifier.citedreferenceWatanabe M, Houten SM, Mataki C et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439: 484 – 9.en_US
dc.identifier.citedreferenceThomas C, Gioiello A, Noriega L et al. TGR5‐mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10: 167 – 77.en_US
dc.identifier.citedreferenceGreve JW, Gouma DJ, Buurman WA. Bile acids inhibit endotoxin‐induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology 1989; 10: 454 – 8.en_US
dc.identifier.citedreferenceKeitel V, Donner M, Winandy S, Kubitz R, Häussinger D. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun 2008; 372: 78 – 84.en_US
dc.identifier.citedreferencePols TW, Nomura M, Harach T et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 2011; 14: 747 – 57.en_US
dc.identifier.citedreferenceCipriani S, Mencarelli A, Chini MG et al. The bile acid receptor GPBAR‐1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS ONE 2011; 6: e25637.en_US
dc.identifier.citedreferenceAkagawa KS. Functional heterogeneity of colony‐stimulating factor‐induced human monocyte‐derived macrophages. Int J Hematol 2002; 76: 27 – 34.en_US
dc.identifier.citedreferenceEvans KA, Budzik BW, Ross S et al. Discovery of 3‐aryl‐4‐isoxazolecarboxamides as TGR5 receptor agonists. J Med Chem 2009; 52: 7962 – 5.en_US
dc.identifier.citedreferenceKanai T, Watanabe M, Okazawa A et al. Macrophage‐derived IL‐18‐mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 2001; 121: 875 – 88.en_US
dc.identifier.citedreferenceWang YD, Chen WD, Yu D, Forman BM, Huang W. The G‐Protein‐coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light‐chain enhancer of activated B cells (NF‐κB) in mice. Hepatology 2011; 54: 1421 – 32.en_US
dc.identifier.citedreferenceKoga K, Takaesu G, Yoshida R, Nakaya M, Kobayashi T, Kinjyo I, Yoshimura A. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c‐Fos protein. Immunity 2009; 30: 372 – 83.en_US
dc.identifier.citedreferenceFiorucci S, Mencarelli A, Palladino G, Cipriani S. Bile‐acid‐activated receptors: targeting TGR5 and farnesoid‐X‐receptor in lipid and glucose disorders. Trends Pharmacol Sci 2009; 30: 570 – 80.en_US
dc.identifier.citedreferenceSato H, Macchiarulo A, Thomas C et al. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure–activity relationships, and molecular modeling studies. J Med Chem 2008; 51: 1831 – 41.en_US
dc.identifier.citedreferenceIchikawa H, Okamoto S, Kamada N et al. Tetomilast suppressed production of proinflammatory cytokines from human monocytes and ameliorated chronic colitis in IL‐10‐deficient mice. Inflamm Bowel Dis 2008; 14: 1483 – 90.en_US
dc.identifier.citedreferenceGalli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011; 12: 1035 – 44.en_US
dc.identifier.citedreferenceGordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953 – 64.en_US
dc.identifier.citedreferenceSmythies LE, Sellers M, Clements RH, Mosteller‐barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005; 115: 66 – 75.en_US
dc.identifier.citedreferenceKamada N, Hisamatsu T, Okamoto S et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1‐dominant chronic colitis through excess production of IL‐12 and IL‐23 in response to bacteria. J Immunol 2005; 175: 6900 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
imm12045.pdf
Size:
477.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.